STOCK TITAN

Insider sale: OCUL (NASDAQ: OCUL) Nadia Waheed sells 3,510 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Nadia K. Waheed submitted a Form 144 reporting a proposed sale of 3,510 shares of common stock tied to restricted stock vesting under a registered plan, dated 02/11/2026. The filing also shows 7,863 shares were sold on 02/12/2026.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 notice of an affiliate sale tied to vested restricted stock.

The filing lists a proposed sale of 3,510 shares dated 02/11/2026 described as "restricted stock vesting under a registered plan" and an executed sale of 7,863 shares on 02/12/2026.

Because Form 144s are notice filings, cash‑flow treatment and sale method are not specified in the excerpt; subsequent transaction details or broker confirmations would appear in other filings or trading records.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the OCUL Form 144 filed by Nadia K. Waheed report?

The filing reports a proposed sale of 3,510 shares tied to restricted stock vesting on 02/11/2026, and a sale of 7,863 shares on 02/12/2026, per the excerpt.

Does the Form 144 specify how the OCUL shares will be sold?

No, the excerpt describes the shares as "restricted stock vesting under a registered plan" but does not specify the sale method or broker execution details in the provided text.

Who is the reporting person on the OCUL Form 144?

The reporting person named in the excerpt is Nadia K. Waheed, with an address listed in Bedford, MA, as the individual associated with the reported transactions.

Are the amounts in the Form 144 confirmed as completed sales?

The excerpt shows a sale of 7,863 shares on 02/12/2026 and a proposed sale of 3,510 shares dated 02/11/2026; confirmation beyond those entries is not included here.
Ocular Therapeut

NASDAQ:OCUL

OCUL Rankings

OCUL Latest News

OCUL Latest SEC Filings

OCUL Stock Data

1.53B
210.92M
Biotechnology
Pharmaceutical Preparations
Link
United States
BEDFORD